Home » Authors » Cynthia Robbins-Roth

Articles by Cynthia Robbins-Roth

Maybe It's Time to Reinvent Bio's Entrepreneurial Spirit

Feb. 4, 2008

By Cynthia Robbins-Roth

Merckifying Genentech And Other Bio Rhythms

Dec. 10, 2007

By Cynthia Robbins-Roth

Merckifying Genentech And Other Bio Rhythms

Dec. 10, 2007

By Cynthia Robbins-Roth

Name (Changing) Game Is An Old Biotech Trick

Nov. 12, 2007

By Cynthia Robbins-Roth

Name (Changing) Game Is An Old Biotech Trick

Nov. 12, 2007

By Cynthia Robbins-Roth

Academia May Be Suffering But Biotech Chugs Along

Oct. 8, 2007

By Cynthia Robbins-Roth

Academia May Be Suffering But Biotech Chugs Along

Oct. 8, 2007

By Cynthia Robbins-Roth

Revenge of the Entrepreneurs: See It Now At TheFunded.com

Sep. 10, 2007

By Cynthia Robbins-Roth

Revenge of the Entrepreneurs: See It Now At TheFunded.com

Sep. 10, 2007

By Cynthia Robbins-Roth

Why Do It? Because We Can! Favorite Stupid Biotech Tricks

Aug. 13, 2007

By Cynthia Robbins-Roth

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...